{
    "title": "103_s1429",
    "content": "The Act titled \"Women and AIDS Research Initiative Amendments of 1993\" establishes a program for research on women and AIDS. This program is added to the Public Health Service Act. The Act \"Women and AIDS Research Initiative Amendments of 1993\" establishes a program for biomedical and behavioral research on HIV infection in women, including prevention research. The Secretary may conduct research directly or provide grants to entities for research. Research includes studying HIV transmission to women, the relationship between HIV infection and other sexually transmitted diseases, and clinical trials on preventing HIV infection by treating STDs in women. The Act \"Women and AIDS Research Initiative Amendments of 1993\" focuses on preventing HIV infection in women by addressing sexually transmitted diseases. Research includes prevention measures such as rapid diagnostic tests, single-dose therapy, prevention methods for women, and substance abuse reduction programs. The Act \"Women and AIDS Research Initiative Amendments of 1993\" focuses on prevention programs to reduce substance abuse among women, research on symptoms and treatment of HIV infection in women, and behavioral research on prevention and educational programs. Clinical trials involving women as subjects must include gynecological evaluations. In clinical trials under this title, female subjects infected with HIV must undergo gynecological examinations before participation. Results are analyzed to understand the relationship between gynecological conditions and HIV infection. The Secretary will conduct clinical trials to determine the effectiveness of standard treatments for gynecological conditions arising from HIV infection. Additionally, trials will assess the effectiveness of treatment protocols approved for men on women with HIV. Support services will be provided for these clinical trials. Support services, including transportation, child care, medical and mental health services, and services addressing domestic violence, will be provided to women participating in clinical trials under this title to enable their participation. Services will be tailored to meet the specific needs of women in clinical trials, including training. The Secretary shall conduct or support research on barrier methods for preventing sexually transmitted diseases, including HIV, that women can use without their partner's knowledge. Priority will be given to identified research needs and opportunities. The Secretary shall prioritize research on topical microbicides, including early infectious processes, formulation of new preparations, clinical testing, and acceptability studies. Epidemiological research will also be conducted or supported. The Secretary will conduct or support epidemiological research to determine risk factors for HIV infection in women, including contraceptive methods, tampon use, STDs, substance abuse (including crack cocaine), and sexual activity. The Secretary is conducting a study on the progression of HIV infection in women, known as the Women's Interagency HIV Study. The study includes at least 5,000 women with HIV, will be conducted at multiple sites, and will last for a minimum of 8 years. The Secretary is conducting a study on HIV infection progression in women for a minimum of 8 years. The study will address the relationship between CD4 cells and serious illnesses in women with HIV, including gynecological conditions not currently on the CDC's list. The term 'human immunodeficiency virus' refers to the agent causing AIDS. For the prevention of HIV, authorizations of appropriations are provided for clinical trials, with $20,000,000 for fiscal year 1994 and additional funds for 1995-1996. For fiscal years 1994 through 1996, appropriations are authorized for various subsections, including $10,000,000 for subsection (c)(3) and $15,000,000 for subsection (c)(4). Additionally, $30,000,000 is authorized for prevention programs under subsection (d)(1). For fiscal years 1994 through 1996, appropriations are authorized for subsections (d)(1), (d)(2), and (e) totaling $55,000,000."
}